Although these previous studies showed the potential role of DLX2 in the tumor progression and metastasis involving TGF-β signaling, the detailed biological role of DLX2 in the acquirement of CSC and EMT characteristics of irradiated cancer cells remains largely unknown. The gene discussed is TGFB1; the disease is cancer.